Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
AstraZeneca
Mallinckrodt
Covington
Argus Health
Farmers Insurance
Teva
Chubb
Novartis
Daiichi Sankyo

Generated: December 11, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Sweden Patent: 9803929

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Valeant BermudaXERESEacyclovir; hydrocortisoneCREAM;TOPICAL022436-001Jul 31, 2009RXYesYes► Subscribe► Subscribe► SubscribeYCOMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND CHILDREN (6 YEARS OF AGE AND OLDER)
Valeant BermudaXERESEacyclovir; hydrocortisoneCREAM;TOPICAL022436-001Jul 31, 2009RXYesYes► Subscribe► Subscribe► SubscribeYNEW COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND ADOLESCENTS (12 YEARS OF AGE AND OLDER)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist